Medtronic receives US FDA Breakthrough Device Designation for complex EVAR device

Source: BIBA MedTech Aortic Segmentation Monitor The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Medtronic for its novel Valiant thoracoabdominal aneurysm (TAAA) stent graft. A press release reports that the device is designed to offer an off-the-shelf solution for complex endovascular aneurysm repair (EVAR) procedures, adding that [...]

2019-10-24T08:44:10+00:00October 24th, 2019|Tags: , , , , , |

Aortic Insights Q1 2019

Source: BIBA MedTech Aortic Segmentation Monitor Aortic Insights is a quarterly report that provides in-depth analysis of the key findings of the Aortic Segmentation Monitor (BIBA MedTech Insights). Each quarter, the monitor tracks aortic procedures performed in Western Europe. It looks at the segment treated (infrarenal, complex, and thoracic), type of procedure [...]

2019-11-12T11:53:13+00:00October 8th, 2019|Tags: , |
Go to Top